+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Europe Cosmetic CDMO Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (Europe)

  • PDF Icon

    Report

  • 222 Pages
  • April 2025
  • Region: Europe
  • Fairfield Market Research
  • ID: 6067281
The Europe cosmetic CDMO (Contract Development and Manufacturing Organization) market is undergoing a remarkable transformation, characterized by technological innovation, evolving consumer preferences, and increasing demand for sustainable and customized beauty solutions. With a projected compound annual growth rate (CAGR) of 5.26% from 2025 to 2032, the market is expected to rise from US$4.45 Bn in 2025 to US$6.37 Bn by the end of 2032.

CDMOs in the region are emerging as critical enablers for beauty and personal care brands seeking agility, expertise, and compliance in bringing their products to market. As brands outsource essential development and manufacturing tasks, CDMOs are playing a pivotal role in enhancing efficiency, quality, and innovation across the beauty product value chain.

Market Insights

The European cosmetic CDMO market is marked by growing collaboration between cosmetic brands and third-party manufacturers. CDMOs offer a suite of services including formulation development, pilot studies, contract manufacturing, bulk preparation and scale-up, safety testing, and packaging. These services allow cosmetic companies to remain focused on core brand strategies, marketing, and product positioning while relying on CDMOs for technical execution.

A significant aspect of market growth is the industry's capacity to deliver flexible and scalable manufacturing processes tailored to client-specific needs. The increasing emphasis on regulatory compliance, quality assurance, and technological advancement is enabling CDMOs to produce high-end, safe, and customized cosmetic products for diverse market segments.

Market Drivers

Rising Demand for Personalized Skincare Solutions

One of the key growth drivers in the Europe cosmetic CDMO market is the increasing consumer inclination toward customized skincare solutions. With consumers becoming more aware of their specific skin needs and seeking products designed for their individual concerns, cosmetic brands are focusing on developing personalized offerings. CDMOs facilitate this trend by offering advanced formulation services that align with the demand for targeted, bespoke skincare.

Outsourcing for Operational Efficiency

The growing trend of outsourcing development and manufacturing functions in the beauty industry is further fueling market expansion. Brands prefer to collaborate with experienced CDMOs to gain access to advanced infrastructure, R&D capabilities, and technical know-how without the burden of investing heavily in internal resources. This trend allows them to bring products to market faster, with reduced cost and operational risk.

Business Opportunity

Sustainability and Ethical Beauty

Consumer awareness around environmental sustainability and ethical sourcing has created new business avenues for CDMOs. Brands are seeking partners that can formulate and manufacture products using eco-friendly ingredients and sustainable packaging. CDMOs are capitalizing on this shift by integrating green technologies and environmentally responsible practices into their operations.

From using biodegradable materials to incorporating renewable energy sources in production, these sustainability-focused strategies are enabling CDMOs to attract environmentally conscious brands and consumers. As regulatory frameworks around sustainability evolve, early adopters of green manufacturing stand to benefit significantly.

Natural and Clean Beauty Expansion

The surge in popularity of natural and clean beauty products presents another high-potential opportunity. CDMOs are increasingly focusing on plant-based formulations free from synthetic chemicals and allergens. Their expertise in sourcing natural ingredients and ensuring safety and efficacy is helping brands tap into a consumer base that values transparency and health-conscious beauty.

Region Analysis

Italy Leads in Innovation and Quality

Italy stands out as a major contributor to the European cosmetic CDMO market. The country’s legacy in beauty and skincare, combined with its strong manufacturing base, makes it a central hub for cosmetic outsourcing. Italian CDMOs are renowned for their emphasis on research, aesthetics, and compliance, providing end-to-end services from product conceptualization to packaging.

Italy’s strategic geographic location further enhances its appeal by offering efficient trade connectivity and supply chain advantages within Europe. With a vibrant cosmetic ecosystem and established infrastructure, Italy continues to be a key player shaping the direction of the European cosmetic CDMO market.

Key Players

The Europe cosmetic CDMO market is highly competitive, with several companies making strategic investments to strengthen their market positions. Leading players include:

  • Catalent, Inc
  • Pierre Fabre Group
  • INTERCOS S.p.A
  • Biofarma Srl C.F.
  • FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. (Euro Cosmetics)
  • Merck KGaA
  • C.O.C. Farmaceutici Srl
  • Cosmoproject
  • Farcoderma S.p.A.
  • IRA Istituto Ricerche Applicate S.p.A
  • Biogei Cosmetici srl
  • O.F.I. Officina Farmaceutica Italiana
  • Eley s.r.l
  • S.I.P.R.E.S.
  • SAN.ECO.VIT. SRL
  • Cleys
These companies are differentiating themselves through strong R&D, compliance with evolving regulations, expansion of manufacturing capacity, and sustainable product development.

Strategic Developments

Facility Expansion:

Leading CDMOs are investing in expanding their manufacturing capacities through new production units and state-of-the-art technologies. These investments aim to meet rising demand and reduce production lead times.

Collaborations and Partnerships:

Strategic collaborations are emerging across the cosmetic industry value chain. CDMOs are partnering with raw material suppliers, brands, and technology firms to accelerate product development and improve competitive edge.

Green Manufacturing:

A heightened emphasis on sustainable practices is influencing operational strategies. CDMOs are integrating renewable energy use, recyclable packaging, and biodegradable formulations to align with consumer demand and regulatory expectations.

Analyst Perspective

The Europe cosmetic CDMO market is set to experience sustained momentum as both supply-side capabilities and demand-side expectations evolve. The convergence of innovation, sustainability, and outsourcing will continue to define the trajectory of the market. CDMOs that invest in green technologies, customization capabilities, and regulatory readiness will be well-positioned to capture a growing share of this dynamic market.

Additionally, as demand for advanced skincare, natural cosmetics, and high-performance beauty products rises, CDMOs will play an increasingly central role in supporting brand innovation and expansion strategies. With a strong foundation in technical expertise and manufacturing excellence, the Europe cosmetic CDMO market is poised for a vibrant and opportunity-rich future.

________________________________________

Market Segmentation

By Service Type

  • Contract Development
  • Formulation Development
  • Pilot Studies
  • Contract Manufacturing
  • Bulk Preparation & Scale-up
  • Safety Testing
  • Filling & Packaging (Close Jar, Bottles, Tubes, Roll-ons)

By Product

  • Hair Products
  • Skin Products
  • Lip Products
  • Eye Products
  • Body Hygiene
  • Oral Hygiene

By Form

  • Solid Form & Powder
  • Lotions
  • Creams
  • Others (Gels, Sprays, Syrups)

By Country

  • Italy

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Europe Cosmetic CDMO Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Europe Cosmetic CDMO Market Outlook, 2019-2032
3.1. Europe Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Contract Development
3.1.1.1.1. Pilot Studies
3.1.1.1.2. Formulation Development
3.1.1.2. Contract Manufacturing
3.1.1.2.1. Bulk Preparation & Scale Up
3.1.1.2.2. Safety Testing
3.1.1.2.3. Filling & Packaging
3.2. Europe Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Skin Products
3.2.1.2. Body Hygiene Products
3.2.1.3. Hair Products
3.2.1.4. Eyecare Products
3.2.1.5. Lip Products
3.3. Europe Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Lotions
3.3.1.2. Creams
3.3.1.3. Solid Form & Powder
3.3.1.4. Other Forms
3.4. Europe Cosmetic CDMO Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Italy
3.4.1.2. France
3.4.1.3. Germany
3.4.1.4. UK
3.4.1.5. Spain
3.4.1.6. Greece
3.4.1.7. Rest of Europe
4. Italy Cosmetic CDMO Market Outlook, 2019-2032
4.1. Italy Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Contract Development
4.1.1.1.1. Pilot Studies
4.1.1.1.2. Formulation Development
4.1.1.2. Contract Manufacturing
4.1.1.2.1. Bulk Preparation & Scale Up
4.1.1.2.2. Safety Testing
4.1.1.2.3. Filling & Packaging
4.2. Italy Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Skin Products
4.2.1.2. Body Hygiene Products
4.2.1.3. Hair Products
4.2.1.4. Eyecare Products
4.2.1.5. Lip Products
4.2.1.6. Oral Hygiene
4.3. Italy Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Lotions
4.3.1.2. Creams
4.3.1.3. Solid Form & Powder
4.3.1.4. Other Forms
5. France Cosmetic CDMO Market Outlook, 2019-2032
5.1. France Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Contract Development
5.1.1.1.1. Pilot Studies
5.1.1.1.2. Formulation Development
5.1.1.2. Contract Manufacturing
5.1.1.2.1. Bulk Preparation & Scale Up
5.1.1.2.2. Safety Testing
5.1.1.2.3. Filling & Packaging
5.2. France Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Skin Products
5.2.1.2. Body Hygiene Products
5.2.1.3. Hair Products
5.2.1.4. Eyecare Products
5.2.1.5. Lip Products
5.2.1.6. Oral Hygiene
5.3. France Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Lotions
5.3.1.2. Creams
5.3.1.3. Solid Form & Powder
5.3.1.4. Other Forms
6. Germany Cosmetic CDMO Market Outlook, 2019-2032
6.1. Germany Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Contract Development
6.1.1.1.1. Pilot Studies
6.1.1.1.2. Formulation Development
6.1.1.2. Contract Manufacturing
6.1.1.2.1. Bulk Preparation & Scale Up
6.1.1.2.2. Safety Testing
6.1.1.2.3. Filling & Packaging
6.2. Germany Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Skin Products
6.2.1.2. Body Hygiene Products
6.2.1.3. Hair Products
6.2.1.4. Eyecare Products
6.2.1.5. Lip Products
6.2.1.6. Oral Hygiene
6.3. Germany Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Lotions
6.3.1.2. Creams
6.3.1.3. Solid Form & Powder
6.3.1.4. Other Forms
7. UK Cosmetic CDMO Market Outlook, 2019-2032
7.1. UK Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Contract Development
7.1.1.1.1. Pilot Studies
7.1.1.1.2. Formulation Development
7.1.1.2. Contract Manufacturing
7.1.1.2.1. Bulk Preparation & Scale Up
7.1.1.2.2. Safety Testing
7.1.1.2.3. Filling & Packaging
7.2. UK Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Skin Products
7.2.1.2. Body Hygiene Products
7.2.1.3. Hair Products
7.2.1.4. Eyecare Products
7.2.1.5. Lip Products
7.2.1.6. Oral Hygiene
7.3. UK Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Lotions
7.3.1.2. Creams
7.3.1.3. Solid Form & Powder
7.3.1.4. Other Forms
8. Spain Cosmetic CDMO Market Outlook, 2019-2032
8.1. Spain Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Contract Development
8.1.1.1.1. Pilot Studies
8.1.1.1.2. Formulation Development
8.1.1.2. Contract Manufacturing
8.1.1.2.1. Bulk Preparation & Scale Up
8.1.1.2.2. Safety Testing
8.1.1.2.3. Filling & Packaging
8.2. Spain Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Skin Products
8.2.1.2. Body Hygiene Products
8.2.1.3. Hair Products
8.2.1.4. Eyecare Products
8.2.1.5. Lip Products
8.2.1.6. Oral Hygiene
8.3. Spain Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Lotions
8.3.1.2. Creams
8.3.1.3. Solid Form & Powder
8.3.1.4. Other Forms
9. Greece Cosmetic CDMO Market Outlook, 2019-2032
9.1. Greece Cosmetic CDMO Market Outlook, by Service, Value (US$ Bn), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Contract Development
9.1.1.1.1. Pilot Studies
9.1.1.1.2. Formulation Development
9.1.1.2. Contract Manufacturing
9.1.1.2.1. Bulk Preparation & Scale Up
9.1.1.2.2. Safety Testing
9.1.1.2.3. Filling & Packaging
9.2. Greece Cosmetic CDMO Market Outlook, by Product, Value (US$ Bn), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Skin Products
9.2.1.2. Body Hygiene Products
9.2.1.3. Hair Products
9.2.1.4. Eyecare Products
9.2.1.5. Lip Products
9.2.1.6. Oral Hygiene
9.3. Greece Cosmetic CDMO Market Outlook, by Form, Value (US$ Bn), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Lotions
9.3.1.2. Creams
9.3.1.3. Solid Form & Powder
9.3.1.4. Other Forms
10. Competitive Landscape
10.1. Company Market Share Analysis, 2025
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. INTERCOS S.p.A
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Biofarma Srl C.F
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Pharmex Group
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. EUROAPI
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. Fareva
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Chemineau
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. DCC PLC
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. Euro Cosmetic
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. C.O.C. Farmaceutici Srl
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Lonza
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
10.3.11. Paragon Nordic
10.3.11.1. Company Overview
10.3.11.2. Product Portfolio
10.3.11.3. Financial Overview
10.3.11.4. Business Strategies and Development
10.3.12. Famar
10.3.12.1. Company Overview
10.3.12.2. Product Portfolio
10.3.12.3. Financial Overview
10.3.12.4. Business Strategies and Development
10.3.13. Scapa Healthcare (Mativ)
10.3.13.1. Company Overview
10.3.13.2. Product Portfolio
10.3.13.3. Financial Overview
10.3.13.4. Business Strategies and Development
10.3.14. Catalent Inc.
10.3.14.1. Company Overview
10.3.14.2. Product Portfolio
10.3.14.3. Financial Overview
10.3.14.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Catalent, Inc
  • Pierre Fabre group
  • INTERCOS S.p.A
  • Biofarma Srl C.F.
  • FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A.(Euro Cosmetics) )
  • Merck KGaA
  • C.O.C. Farmaceutici Srl
  • Cosmoproject
  • Farcoderma S.p.A.
  • IRA Istituto Ricerche Applicate S.p.A
  • Biogei Cosmetici srl
  • O.F.I. Officina Farmaceutica Italiana
  • Eley s.r.l
  • S.I.P.R.E.S.
  • SAN.ECO.VIT. SRL
  • Cleys

Methodology

Loading
LOADING...